Updates in Management of Soft Tissue Sarcoma

Friday, May 15, 2026, 7:30 AM - 4:15 PM, A1-22 Auditorium/ Elmhurst Hospital, Elmhurst, NY


This symposium focuses on updates in diagnosis and multidisciplinary management of selected soft tissue sarcoma cancers. Latest technologies and scientific achievements and clinical guidelines in prevention, diagnosis and treatment will be discussed.

1. To learn diagnostic approaches to soft tissue sarcoma and surgical management.
2. To learn about screening and endoscopic management of GI soft tissue sarcoma.
3. To learn about multidisciplinary management of soft tissue sarcoma.

• Physicians, Allied Health Professionals, Residents and Fellows - $50.00

• Elmhurst & MSH Physicians, Allied Health Professionals, Residents and Fellows - $0.00

• Virtual Only - $30.00

Cancellation Policy

All refund and cancellation requests must be emailed to the CME office at [email protected] by May 8, 2026. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal or less than $50.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (5.00 hours), Non-Physician Attendance (5.00 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. 

Friday, May 15, 2026